Language Select
Varian Logo

Press Releases

January 29, 2018
Varian (NYSE: VAR) today announced that it will webcast a conference call to discuss the details of the agreement, also announced today, to acquire all the outstanding shares of Sirtex Medical... Read more
January 29, 2018
Varian Medical Systems (NYSE: VAR) today announced it has signed an agreement to acquire all the outstanding shares of Sirtex Medical Limited (ASX: SRX) ("Sirtex"), an Australia-based global life... Read more
January 25, 2018
Highlighting the growing adoption of proton therapy systems for the treatment of cancer, Varian (NYSE: VAR) today announced it has reached an agreement with Sylvester Comprehensive Cancer Center... Read more
January 24, 2018
Varian (NYSE: VAR) today announced it has been selected by Proton International to install a Varian ProBeam® Compact single-room proton therapy system in the new University of Alabama at... Read more
January 24, 2018
First Quarter 2018 Summary Revenues of $679 million grew 13 percent Oncology gross orders grew 7 percent; booked 2 new Proton orders GAAP operating earnings of 17.9 percent of revenues; Non-GAAP... Read more
January 08, 2018
Varian (NYSE: VAR) today announced it has signed a Memorandum of Understanding (MoU) with Ping An Health Technology Co., Ltd, to explore a strategic partnership for expanding access to cancer care... Read more
January 08, 2018
Varian (NYSE: VAR) today announced its Halcyon™ system has received Taiwan FDA approval, which allows the company to market this new cancer treatment system in Taiwan. This approval further... Read more
January 03, 2018
Varian (NYSE: VAR) today announced that it will webcast a conference call to discuss its transition to the new Accounting Standard Codification 606. No financial information concerning the just... Read more
December 28, 2017
Varian (NYSE: VAR) today announced the publication of its 2017 annual report. A PDF version of the Varian 2017 annual report is now available at: http://investors.varian.com/varianannualreports.... Read more
December 18, 2017
Varian (NYSE: VAR) today announced that Dow Wilson, president and chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, scheduled for 8:30... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
[email protected]

Monica Prokocki
Director, Investor Relations
650.424.5184
[email protected]